These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 7344792)

  • 1. [Chloroquine in the treatment of porphyria cutanea tarda symptomatica. Twelve years of experience in 307 patients (author's transl)].
    Kordac V; Martásek P; Kaláb M; Semrádová M; Papezová R
    Cas Lek Cesk; 1981 Oct; 120(40):1225-7. PubMed ID: 7344792
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term treatment of porphyria cutanea tarda with low chloroquine doses.
    Holvay E
    Ther Hung; 1981; 29(1):42-6. PubMed ID: 7188240
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of porphyria cutanea tarda with intermittent chloroquine].
    Raff M; Formanek I
    Hautarzt; 1980 Aug; 31(8):437-40. PubMed ID: 7451150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of chloroquine in porphyria cutanea tarda].
    Herrero C; Muniesa A
    Med Cutan Ibero Lat Am; 1980; 8(4-6):139-45. PubMed ID: 7024672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Porphyria cutanea tarda treated with low doses of antimalarial agents; liver findings (author's transl)].
    Chlumský J; Dobiás J; Chlumská A; Malina L
    Cas Lek Cesk; 1977 Nov; 116(45):1404-6. PubMed ID: 603887
    [No Abstract]   [Full Text] [Related]  

  • 6. Porphyria cutanea tarda symptomatica in children treated with chloroquine. Report of four cases with control liver biopsies.
    Tamayo L; Ruiz-Maldonado R; Ridaura C
    J Dermatol; 1985 Aug; 12(4):329-40. PubMed ID: 3910689
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term effect of high-dose, short-course chloroquine therapy on porphyria cutanea tarda.
    Tsega E
    Q J Med; 1987 Nov; 65(247):953-7. PubMed ID: 3455550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Major hypertrichosis in an adult female secondary to porphyria cutanea tarda. Its evolution with chloroquine].
    Michel B; Guillot B; Guilhou JJ; Meynadier J
    Ann Dermatol Venereol; 1983; 110(4):361-3. PubMed ID: 6625460
    [No Abstract]   [Full Text] [Related]  

  • 9. The liver in Ethiopians with porphyria cutanea tarda.
    Tsega E; Damtew B; Landells JW; Besrat A; Seyoum E
    East Afr Med J; 1982 Oct; 59(10):682-8. PubMed ID: 7185559
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic and pathogenetic aspects of porphyria cutanea tarda].
    Köstler E; Seebacher C; Riedel H; Kemmer C
    Hautarzt; 1986 Apr; 37(4):210-6. PubMed ID: 3009356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porphyria Cutanea tarda in Missouri.
    Anderson PC
    Mo Med; 1981 Jun; 78(6):299-302. PubMed ID: 7254176
    [No Abstract]   [Full Text] [Related]  

  • 12. [Modern internal therapy of skin diseases (author's transl)].
    Goerz G
    MMW Munch Med Wochenschr; 1979 Jan; 121(4):133-6. PubMed ID: 104160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of chloroquine therapy in seven cases of porphyria cutanea tarda: influence on clinical and chemical-clinical pictures (author's transl)].
    Arbosti G; Nava C; Ghezzi I; Grisler R; Brambilla G
    Med Lav; 1979; 70(3):239-47. PubMed ID: 470825
    [No Abstract]   [Full Text] [Related]  

  • 14. [Suburoporphyrins in symptomatic hepatic porphyria and in experimental porphyria (author's transl)].
    Kaláb M; Jirsa M; Kordac V; Soldátová H
    Cas Lek Cesk; 1981 Oct; 120(41):1251-4. PubMed ID: 7344798
    [No Abstract]   [Full Text] [Related]  

  • 15. [Porphyria cutanea tarda and lupus erythematosus].
    Köstler E; Heinicke HJ; Schneider F; Riedel H; Hensel J
    Z Gesamte Inn Med; 1989 Sep; 44(17):527-9. PubMed ID: 2588723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prolonged low-dose chloroquin therapy of porphyria cutanea tarda].
    Holvay E
    Orv Hetil; 1981 Jul; 122(30):1839-42. PubMed ID: 7301351
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinico-immunological substantiation of the therapeutic effectiveness of delagil in porphyria cutanea tarda].
    Bidrat MS
    Vestn Dermatol Venerol; 1984 Oct; (10):20-3. PubMed ID: 6516569
    [No Abstract]   [Full Text] [Related]  

  • 18. [Iron metabolism and chloroquine phosphate therapy in porphyria cutanea tarda].
    Köstler E; Pollack P; Seebacher C; Riedel H
    Z Hautkr; 1990 Nov; 65(11):1030-2, 1035. PubMed ID: 2080653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [2 years' experience with combined therapy of symptomatic liver porphyria using pyrimethamine and chloroquine].
    Kaláb M; Cervinka J; Kotal P; Jirsa M; Kordac V; Marecek Z; Soldátová H; Papezová P
    Cas Lek Cesk; 1988 Mar; 127(10):305-9. PubMed ID: 3365727
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative evaluation of the therapeutic effectiveness of small and regular doses of delagil in porphyria cutanea tarda].
    Krivosheev BN
    Vestn Dermatol Venerol; 1981 Sep; (9):50-4. PubMed ID: 7029950
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.